Corval and Rapid Commercialization Partners (RCP) announced today that they are strengthening the commercialization journey for biopharma companies through a collaboration that brings together Corval’s proprietary technology and RCP’s deep commercialization expertise.
Through this new affiliation, biopharma leaders in clinical-stage companies can now access RCP’s deep expertise in optimizing growth and accelerating commercialization together with Corval’s innovative, cloud-based platform that dramatically streamlines efforts to build tailored, multi-year commercialization roadmaps, detailed budgets and full resource plans.
“Our collaboration with RCP marks a significant milestone in our mutual commitment to develop cutting-edge, strategic solutions that address challenges in biopharma commercialization, elevate the approaches used and accelerate the path to the market for innovative treatments,” said Sue Nemetz, Founder and CEO, Corval.
The Corval® Platform provides leaders a step-by-step guide that sets their asset on a path to achieve maximum value, while the RCP approach to commercialization offers clients the ability to begin commercialization without having to commit to a large commercial footprint, at a time when capacity for investment may be minimal or premature.
“We are creating a critical and important shift in how emerging biotech companies approach commercial preparedness,” said Christina Ansted, CEO, RCP. “By working together, we are helping our clients build a solid commercial foundation, elevate their commercialization planning and establish their own internal capabilities and processes along the multi-year journey.”
Leaders from Corval and RCP will be attending the J.P. Morgan Healthcare Conference in San Francisco, Jan. 8-11. To schedule time with RCP email [email protected]. To connect with Corval email [email protected].
About Rapid Commercialization Partners (RCP)
RCP provides the expertise, processes and partnership clinical-stage biotech companies need to maximize revenue though efficient, effective commercialization. With a relentless focus on integrated end-to-end strategic commercialization planning and disciplined execution on strategy, RCP positions biotech companies for commercial success by building a strategic commercial foundation for long-term growth. Visit rcpbio.com for more information.
About Corval
Corval is the leading cloud-based strategic planning platform that enables a fast, efficient, and early start on commercialization planning, detailing cross-functional recommendations on what, when, and how much. The platform serves as the foundation for biopharma commercialization efforts—organizing all facets of commercialization while creating a comprehensive, multi-year view of what you need to do, when you need to do it, and what it will take for success.